Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion type Assertion NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_head.
- NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion description "[The mRNA for RGS9-2 in 29 control hippocampi was 0.185 +/- 0.015 fg per fg of beta-glucuronidase mRNA (average +/- SE), while that in 29 schizophrenia hippocampi was 0.145 +/- 0.015 fg per fg of beta-glucuronidase mRNA (average +/- SE), a reduction of 22%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_provenance.
- NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion evidence source_evidence_literature NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_provenance.
- NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion SIO_000772 17318883 NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_provenance.
- NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion wasDerivedFrom befree-20140225 NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_provenance.
- NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_assertion wasGeneratedBy ECO_0000203 NP513386.RA6fbYJCZ6yhGWmanHfF3bqLGoy6geP97kc4EzSP0B6fE130_provenance.